Market revenue in 2023 | USD 14.6 million |
Market revenue in 2030 | USD 90.7 million |
Growth rate | 29.8% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Therapeutics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Therapeutics, Diagnostics |
Key market players worldwide | Novartis AG ADR, Oncopeptides AB, Bicycle Therapeutics PLC ADR, AstraZeneca PLC, Theratechnologies Inc, Cybrexa Therapeutics, AngioChem, Soricimed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peptide drug conjugates market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 81.51% in 2023. Horizon Databook has segmented the Brazil peptide drug conjugates market based on therapeutics, diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
In LATAM, Brazil has the largest population. Thus, the prevalence of target diseases in the country is high, which leads to an increased demand for therapeutics. Moreover, cardiovascular diseases are the leading causes of death in the country.
Brazil has been witnessing positive economic growth due to the region's recent financial and political stability. The peptide drug conjugate market in Brazil is witnessing a competitive landscape characterized by intriguing dynamics.
As the country's pharmaceutical sector grows, both domestic and international players are actively participating in shaping the market. The market competition is driven by the growing demand for targeted and personalized therapies, leading to intensified research and development efforts.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil peptide drug conjugates market , including forecasts for subscribers. This country databook contains high-level insights into Brazil peptide drug conjugates market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account